Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1520407

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1520407

Blood Plasma Derivatives Market Report by Type, Application, End User, and Region 2024-2032

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2999
PDF & Excel (5 User License)
USD 3999
PDF & Excel (Corporate License)
USD 4999

Add to Cart

The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood plasma derivatives market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Albumin

Factor VIII

Factor IX

Immunoglobulin

Hyperimmune Globulin

Others

Breakup by Application:

Hemophilia

Hypogammaglobulinemia

Immunodeficiency Diseases

Von Willebrand's Disease

Others

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global blood plasma derivatives market in 2023?
  • 2. What is the expected growth rate of the global blood plasma derivatives market during 2024-2032?
  • 3. What are the key factors driving the global blood plasma derivatives market?
  • 4. What has been the impact of COVID-19 on the global blood plasma derivatives market?
  • 5. What is the breakup of the global blood plasma derivatives market based on the type?
  • 6. What is the breakup of the global blood plasma derivatives market based on the end-user?
  • 7. What are the key regions in the global blood plasma derivatives market?
  • 8. Who are the key players/companies in the global blood plasma derivatives market?
Product Code: SR112024A5371

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
Product Code: SR112024A5371

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!